BOIOF (Bioton) Other Gross PPE : $9.36 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Bioton Other Gross PPE?

Bioton's Other Gross PPE for the quarter that ended in Jun. 2024 was $9.36 Mil.

Bioton's quarterly Other Gross PPE increased from Dec. 2023 ($9.83 Mil) to Mar. 2024 ($80.95 Mil) but then declined from Mar. 2024 ($80.95 Mil) to Jun. 2024 ($9.36 Mil).

Bioton's annual Other Gross PPE increased from Dec. 2021 ($9.26 Mil) to Dec. 2022 ($9.27 Mil) and increased from Dec. 2022 ($9.27 Mil) to Dec. 2023 ($9.83 Mil).

Bioton Other Gross PPE Historical Data

The historical data trend for Bioton's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Other Gross PPE Chart

Bioton Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Gross PPE

Get a 7-Day Free Trial

6.40

6.23

9.26

9.27

9.83

Bioton Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Other Gross PPE	Get a 7-Day Free Trial															9.52	74.60	9.83	80.95	9.36

Bioton Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Bioton Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (OTCPK:BOIOF) » Definitions » Other Gross PPE

Comparable Companies

Traded in Other Exchanges

BIO:Poland 7U5:Germany

Address

Ul. Staro?ci?ska 5, Warszawa, POL, 02-516

Website

http://www.bioton.pl

Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton Headlines

No Headlines